Concerns are increasing in the EU about the use of chemicals employed in the manufacture of the recreational drug GHB. The statement comes in a new report GHB and its precursor GBL: an emerging trend case study, published today by the EU drugs agency (EMCDDA) as part of its E-POD project to track new patterns of drug use in Europe.
Posted by Administrator on 03/25 at 12:00 AM in
Share this:
(0) Comments
Safer Student Nights
eBulletin
Poll
